{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:13:05Z","timestamp":1792015985411,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000943","name":"Australian Commonwealth Scientific Industrial and research Organization","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000943","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001798","name":"Edith Cowan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001798","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mental Health Research Institute"},{"DOI":"10.13039\/501100001001","name":"Alzheimer's Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Ageing Research Institute"},{"name":"Austin Health"},{"name":"CogState Ltd"},{"name":"Hollywood Private Hospital"},{"name":"Sir Charles Gardner Hospital"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science and Industry Endowment Fund"},{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.neurobiolaging.2014.12.008","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T07:06:25Z","timestamp":1418281585000},"page":"1239-1244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["APOE \u03b54 moderates amyloid-related memory decline in preclinical Alzheimer's disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Yen Ying","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Villemagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Pietrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karra","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph N.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Maruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMoa0809437","article-title":"Longitudinal modeling of age-related memory decline and the APOE\u03b54 effect","volume":"361","author":"Caselli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jalz.2013.01.004","article-title":"The neuropsychology of normal aging and preclinical Alzheimer's disease","volume":"10","author":"Caselli","year":"2014","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib4","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib5","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182661f74","article-title":"Amyloid-\u03b2 assessed by florbetapir F 18 PET and 18-month cognitive decline","volume":"79","author":"Doraiswamy","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib6","doi-asserted-by":"crossref","first-page":",672","DOI":"10.1017\/S1041610209009405","article-title":"The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease","volume":"21","author":"Ellis","year":"2009","journal-title":"Int. Psychogeriatrics"},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jalz.2013.11.009","article-title":"Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data","volume":"10","author":"Gomar","year":"2014","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib8","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/WNL.0000000000000386","article-title":"Rates of B-amyloid accumulation are independent of hippocampal neurodegeneration","volume":"82","author":"Jack","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of A\u03b2","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/WNL.0b013e31824365ab","article-title":"APOE modifies the association between A\u03b2 load and cognition in cognitively normal older adults","volume":"78","author":"Kantarci","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib11","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/WNL.0000000000000438","article-title":"\u03b2-Amyloidosis and neurodegeneration in Alzheimer disease: who's on first?","volume":"82","author":"Knopman","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jalz.2012.07.004","article-title":"A\u03b2 amyloid, cognition and APOE genotype in healthy older adults","volume":"9","author":"Lim","year":"2013","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1037\/a0032321","article-title":"Cognitive consequences of high A\u03b2 amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease","volume":"27","author":"Lim","year":"2013","journal-title":"Neuropsychology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2014.12.008_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3233\/JAD-121771","article-title":"Cognitive decline in adults with mild cognitive impairment and high A\u03b2amyloid: prodromal Alzheimer's disease?","volume":"33","author":"Lim","year":"2013","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib15","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1212\/WNL.0b013e31826e9ae6","article-title":"Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults","volume":"79","author":"Lim","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/brain\/awt286","article-title":"Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease","volume":"137","author":"Lim","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib18","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.0000000000000431","article-title":"Amyloid and APOE E4 interact to influence short-term decline in preclinical Alzheimer's disease","volume":"82","author":"Mormino","year":"2014","journal-title":"Neurology"},{"issue":"30","key":"10.1016\/j.neurobiolaging.2014.12.008_bib19","first-page":"1","article-title":"Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease","volume":"1","author":"Maruff","year":"2013","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/sim.2323","article-title":"Confidence intervals for an effect size measure based on the Mann\u2013Whitney statistic. Part 1: general issues and tail-area-based methods","volume":"25","author":"Newcombe","year":"2006","journal-title":"Stat. Med."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1017\/S1355617714000113","article-title":"Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's disease","volume":"20","author":"Okonkwo","year":"2014","journal-title":"J. Int. Neuropsychological. Soc."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0b013e3182918ca6","article-title":"Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later","volume":"80","author":"Roe","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","article-title":"Imaging of amyloid \u03b2 in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism","volume":"7","author":"Rowe","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.24040","article-title":"Predicting Alzheimer disease with \u03b2-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing","volume":"74","author":"Rowe","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib25","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.12.008_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014008057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014008057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:23:01Z","timestamp":1759317781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458014008057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0197458014008057"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.12.008","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOE \u03b54 moderates amyloid-related memory decline in preclinical Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}